AGI BIOPHARMACEUTICALS
AGI Biopharmaceuticals, Ltd., a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application.
AGI BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
Ireland, Indiana, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
4.71 M USD
Similar Organizations
Circuport
Circuport Circuport System offers an implantable port that provides vascular access systems for hemodialysis patients.
Ichorion Therapeutics
Ichorion Therapeutics is a biopharmaceutical company that develop treatments for rare diseases with unmet medical needs.
Leptos Biomedical
Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity.
MirImmune
MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer.
Quadriga BioSciences
Quadriga BioSciences is a pharmaceutical company developing proprietary targeted cancer therapies.
Investors List
Mentor Capital Partners
Mentor Capital Partners investment in Venture Round - AGI Biopharmaceuticals
More informations about "AGI Biopharmaceuticals"
AGI - Strategy & Vision Investor Presentation vF
•AGI equipment and solutions are uniquely positioned within the agriculture sector, serving as the connection between the farm and the plate AGI is a Diversified Platform Focused on the …See details»
AGI Biopharmaceuticals - Funding, Financials, Valuation & Investors
Organization. AGI Biopharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Funding Rounds 1. obfuscated. ... AGI …See details»
AGI Biopharmaceuticals - Products, Competitors, Financials, …
AGI Biopharmaceuticals is a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application. Use the CB Insights Platform to explore AGI …See details»
AGI Biopharmaceuticals Ltd Company Profile, Financial and …
AGI Biopharmaceuticals, Ltd., a biotechnology company, develops novel immune-therapeutic cancer treatments. The company was incorporated in 2009 and is based in the United …See details»
AGI Biopharmaceuticals Ltd - Company Profile and News
Company profile page for AGI Biopharmaceuticals Ltd including stock price, company news, executives, board members, and contact informationSee details»
AGI Biopharmaceuticals - Crunchbase
AGI Biopharmaceuticals offers a patented melanoma vaccine with future multi-cancer applications.See details»
AGI Biopharmaceuticals - Web3 Crypto Company Profile, Funding ...
AGI Biopharmaceuticals offers a patented melanoma vaccine with future multi-cancer applications. News; Insight; Currencies; Columns; Events; Search. Recently Searched Hot …See details»
AGI Biopharmaceuticals - PitchBook
AGI Biopharmaceuticals General Information Description. Developer of melanoma vaccines. The company caters to the healthcare industry and specializes in developing melanoma vaccines …See details»
Agios
Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and …See details»
Agi Biopharmaceuticals Poland Sp. z o.o. (Poland) - EMIS
Oct 18, 2023 Agi Biopharmaceuticals Poland Sp. z o.o. is an enterprise located in Poland, with the main office in Poznan. It operates in the Research and Development in Biotechnology …See details»
Venture Round - AGI Biopharmaceuticals - 2011-11-28 - Crunchbase
AGI Biopharmaceuticals raised $4710000 on 2011-11-28 in Venture Round. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»
AGI Biopharmaceuticals (AGI Biopharmaceuticals) - 药物管线_专 …
了解AGI Biopharmaceuticals (AGI Biopharmaceuticals)公司的药物管线，治疗领域，技术平台，以及它的。See details»
AGI Biopharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See AGI Biopharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on AGI Biopharmaceuticals's post-money valuation and revenue.See details»
The Coming Wave: How AGI and ASI Could Reshape Life Sciences
Jan 24, 2025 AGI and its successor, ASI, have the potential to revolutionize the life sciences by accelerating drug discovery, reimagining clinical trials, and enabling truly personalized …See details»
Cancer vaccine - AGI Biopharmaceuticals - AdisInsight
AGI Biopharmaceuticals is developing a vaccine for use in multiple types of cancer. Melanoma is the first cancer being targeted and six studies in human Cancer vaccine - AGI …See details»
AGI Biopharmaceuticals | IT History Society
AGI Biopharmaceuticals offers a patented melanoma vaccine with future multi-cancer applications.AGI Biopharmaceuticals, Ltd., a European firm that has developed a patented, …See details»
Agi Hamburger, Ph.D. - A2 Biotherapeutics
Prior to A2 Bio, Agi spent 12 years at Amgen where she held numerous positions in the Therapeutic Discovery organization. During this time, Agi made significant contributions to …See details»
How AGI Will Transform Drug Discovery and Healthcare - LinkedIn
Mar 8, 2025 Even if AGI speeds up drug development, regulatory approvals will still take time, and new frameworks may be needed to oversee AI-driven research. Ethical and Safety …See details»
‘We’re Definitely Going to Build a Bunker Before We Release AGI’
16 hours ago Musk left the organization in early 2018 and took his money with him. To plug the hole, Altman reformulated OpenAI’s legal structure, creating a new “capped-profit” arm within …See details»
AGI Biopharmaceuticals - Updates, News, Events, Signals & Triggers
AGI Biopharmaceuticals offers a patented melanoma vaccine with future multi-cancer applications.See details»